Response to treatment in Brazilian patients with chronic hepatitis C is associated with a single-nucleotide polymorphism near the interleukin-28B gene

A single-nucleotide polymorphism (SNP) upstream of interleukin (IL)28B was recently identified as an important predictor of the outcome of chronic hepatitis C patients treated with pegylated interferon plus ribavirin (PEG-IFN/RBV). The aim of this study was to investigate the association between the...

Full description

Bibliographic Details
Main Authors: Tarciana Grandi, Cláudia Maria Dornelles da Silva, Karine Medeiros Amaral, Paulo Dornelles Picon, Cintia Costi, Nicole Nascimento da Fré, Marilu Fiegenbaum, Christian Niel, Maria Lucia Rosa Rossetti
Format: Article
Language:English
Published: Fundação Oswaldo Cruz (FIOCRUZ) 2013-02-01
Series:Memorias do Instituto Oswaldo Cruz
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762013000100008
_version_ 1827879715624452096
author Tarciana Grandi
Cláudia Maria Dornelles da Silva
Karine Medeiros Amaral
Paulo Dornelles Picon
Cintia Costi
Nicole Nascimento da Fré
Marilu Fiegenbaum
Christian Niel
Maria Lucia Rosa Rossetti
author_facet Tarciana Grandi
Cláudia Maria Dornelles da Silva
Karine Medeiros Amaral
Paulo Dornelles Picon
Cintia Costi
Nicole Nascimento da Fré
Marilu Fiegenbaum
Christian Niel
Maria Lucia Rosa Rossetti
author_sort Tarciana Grandi
collection DOAJ
description A single-nucleotide polymorphism (SNP) upstream of interleukin (IL)28B was recently identified as an important predictor of the outcome of chronic hepatitis C patients treated with pegylated interferon plus ribavirin (PEG-IFN/RBV). The aim of this study was to investigate the association between the IL28B gene polymorphism (rs12979860) and virological response in chronic hepatitis C patients. Brazilian patients (n = 263) who were infected with hepatitis C virus (HCV) genotype 1 and were receiving PEG-IFN/RBV were genotyped. Early virological response (EVR) (12 weeks), end-of-treatment response (EOTR) (48 weeks), sustained virological response (SVR) (72 weeks) and relapse were evaluated using conventional and quantitative polymerase chain reaction (PCR) assays. The frequency of the C allele in the population was 39%. Overall, 43% of patients experienced SVR. The IL28B CC genotype was significantly associated with higher treatment response rates and a lower relapse rate compared to the other genotypes [84% vs. 58% EVR, 92% vs. 63% EOTR, 76% vs. 38% SVR and 17% vs. 40% relapse rate in CC vs. other genotypes (CT and TT), respectively]. Thus, the IL28B genotype appears to be a strong predictor of SVR following PEG-IFN/RBV therapy in treatment-naïve Brazilian patients infected with HCV genotype 1. This study, together with similar research examining other SNPs, should help to define adequate protocols for the treatment of patients infected with HCV genotype 1, especially those with a poor prognosis.
first_indexed 2024-03-12T18:10:23Z
format Article
id doaj.art-70e80340db0b4e47802024998359def2
institution Directory Open Access Journal
issn 0074-0276
1678-8060
language English
last_indexed 2024-03-12T18:10:23Z
publishDate 2013-02-01
publisher Fundação Oswaldo Cruz (FIOCRUZ)
record_format Article
series Memorias do Instituto Oswaldo Cruz
spelling doaj.art-70e80340db0b4e47802024998359def22023-08-02T09:15:52ZengFundação Oswaldo Cruz (FIOCRUZ)Memorias do Instituto Oswaldo Cruz0074-02761678-80602013-02-0110814853Response to treatment in Brazilian patients with chronic hepatitis C is associated with a single-nucleotide polymorphism near the interleukin-28B geneTarciana GrandiCláudia Maria Dornelles da SilvaKarine Medeiros AmaralPaulo Dornelles PiconCintia CostiNicole Nascimento da FréMarilu FiegenbaumChristian NielMaria Lucia Rosa RossettiA single-nucleotide polymorphism (SNP) upstream of interleukin (IL)28B was recently identified as an important predictor of the outcome of chronic hepatitis C patients treated with pegylated interferon plus ribavirin (PEG-IFN/RBV). The aim of this study was to investigate the association between the IL28B gene polymorphism (rs12979860) and virological response in chronic hepatitis C patients. Brazilian patients (n = 263) who were infected with hepatitis C virus (HCV) genotype 1 and were receiving PEG-IFN/RBV were genotyped. Early virological response (EVR) (12 weeks), end-of-treatment response (EOTR) (48 weeks), sustained virological response (SVR) (72 weeks) and relapse were evaluated using conventional and quantitative polymerase chain reaction (PCR) assays. The frequency of the C allele in the population was 39%. Overall, 43% of patients experienced SVR. The IL28B CC genotype was significantly associated with higher treatment response rates and a lower relapse rate compared to the other genotypes [84% vs. 58% EVR, 92% vs. 63% EOTR, 76% vs. 38% SVR and 17% vs. 40% relapse rate in CC vs. other genotypes (CT and TT), respectively]. Thus, the IL28B genotype appears to be a strong predictor of SVR following PEG-IFN/RBV therapy in treatment-naïve Brazilian patients infected with HCV genotype 1. This study, together with similar research examining other SNPs, should help to define adequate protocols for the treatment of patients infected with HCV genotype 1, especially those with a poor prognosis.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762013000100008IL28BHCVvirological responsetreatmentBrazil
spellingShingle Tarciana Grandi
Cláudia Maria Dornelles da Silva
Karine Medeiros Amaral
Paulo Dornelles Picon
Cintia Costi
Nicole Nascimento da Fré
Marilu Fiegenbaum
Christian Niel
Maria Lucia Rosa Rossetti
Response to treatment in Brazilian patients with chronic hepatitis C is associated with a single-nucleotide polymorphism near the interleukin-28B gene
Memorias do Instituto Oswaldo Cruz
IL28B
HCV
virological response
treatment
Brazil
title Response to treatment in Brazilian patients with chronic hepatitis C is associated with a single-nucleotide polymorphism near the interleukin-28B gene
title_full Response to treatment in Brazilian patients with chronic hepatitis C is associated with a single-nucleotide polymorphism near the interleukin-28B gene
title_fullStr Response to treatment in Brazilian patients with chronic hepatitis C is associated with a single-nucleotide polymorphism near the interleukin-28B gene
title_full_unstemmed Response to treatment in Brazilian patients with chronic hepatitis C is associated with a single-nucleotide polymorphism near the interleukin-28B gene
title_short Response to treatment in Brazilian patients with chronic hepatitis C is associated with a single-nucleotide polymorphism near the interleukin-28B gene
title_sort response to treatment in brazilian patients with chronic hepatitis c is associated with a single nucleotide polymorphism near the interleukin 28b gene
topic IL28B
HCV
virological response
treatment
Brazil
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762013000100008
work_keys_str_mv AT tarcianagrandi responsetotreatmentinbrazilianpatientswithchronichepatitiscisassociatedwithasinglenucleotidepolymorphismneartheinterleukin28bgene
AT claudiamariadornellesdasilva responsetotreatmentinbrazilianpatientswithchronichepatitiscisassociatedwithasinglenucleotidepolymorphismneartheinterleukin28bgene
AT karinemedeirosamaral responsetotreatmentinbrazilianpatientswithchronichepatitiscisassociatedwithasinglenucleotidepolymorphismneartheinterleukin28bgene
AT paulodornellespicon responsetotreatmentinbrazilianpatientswithchronichepatitiscisassociatedwithasinglenucleotidepolymorphismneartheinterleukin28bgene
AT cintiacosti responsetotreatmentinbrazilianpatientswithchronichepatitiscisassociatedwithasinglenucleotidepolymorphismneartheinterleukin28bgene
AT nicolenascimentodafre responsetotreatmentinbrazilianpatientswithchronichepatitiscisassociatedwithasinglenucleotidepolymorphismneartheinterleukin28bgene
AT marilufiegenbaum responsetotreatmentinbrazilianpatientswithchronichepatitiscisassociatedwithasinglenucleotidepolymorphismneartheinterleukin28bgene
AT christianniel responsetotreatmentinbrazilianpatientswithchronichepatitiscisassociatedwithasinglenucleotidepolymorphismneartheinterleukin28bgene
AT marialuciarosarossetti responsetotreatmentinbrazilianpatientswithchronichepatitiscisassociatedwithasinglenucleotidepolymorphismneartheinterleukin28bgene